Quick Answer
BiomX Inc. reported Common Stock Shares Outstanding of 1.59 million shares for the year ending 2025.
- BiomX Inc. showed an increase of +55.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from BiomX Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2018 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: 2.22 million shares | Q2 2019: 2.24 million shares | Q3 2019: 2.30 million shares | Q1 2020: 22.92 million shares | Q2 2020: 23.14 million shares | Q3 2020: 23.17 million shares | Q1 2021: 24.24 million shares | Q2 2021: 24.43 million shares | Q3 2021: 28.20 million shares | Q1 2022: 29.77 million shares | Q2 2022: 29.77 million shares | Q3 2022: 29.98 million shares | Q1 2023: 33.18 million shares | Q2 2023: 45.97 million shares | Q3 2023: 45.97 million shares | Q1 2024: 60.00 million shares | Q2 2024: 7.80 million shares | Q3 2024: 18.18 million shares | Q1 2025: 24.97 million shares | Q2 2025: 26.44 million shares | Q3 2025: 26.80 million shares.
- Over the full 10 years of available data (2018 to 2025), BiomX Inc.'s Common Stock Shares Outstanding has declined by 20.8%.
- Historical annual values: Fiscal year 2025: 1.59 million shares | Fiscal year 2024: 1.02 million shares | Fiscal year 2023: 4.72 million shares | Fiscal year 2022: 29.98 million shares | Fiscal year 2021: 29.75 million shares | Fiscal year 2020: 23.26 million shares | Fiscal year 2019: 22.86 million shares | Fiscal year 2019: 2.24 million shares | Fiscal year 2018: 2.31 million shares | Fiscal year 2018: 2.01 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: